scholarly journals Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension

2019 ◽  
Vol 54 (9) ◽  
pp. 792-803 ◽  
Author(s):  
Atsushi Nakajima ◽  
Kazuhiko Shinbo ◽  
Akira Oota ◽  
Yoshikazu Kinoshita
Keyword(s):  
Polyethylene Glycol ◽  
Chronic Constipation ◽  
Controlled Study ◽  
Open Label ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Open Label Extension

Tu1627 - Linaclotide is Effective and Safe for Patients with Chronic Constipation in Japan: A Phase III Randomized, Double-Blind, Placebo-Controlled Study with a Long-Term Open-Label Extension Study

2018 ◽  
Vol 154 (6) ◽  
pp. S-973-S-974
Author(s):  
Shin Fukudo ◽  
Hiroto Miwa ◽  
Atsushi Nakajima ◽  
Yoshikazu Kinoshita ◽  
Masanori Kosako ◽  
...  
Keyword(s):  
Chronic Constipation ◽  
Phase Iii ◽  
Extension Study ◽  
Controlled Study ◽  
Open Label ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Open Label Extension

scholarly journals High‐dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double‐blind, placebo‐controlled study with a long‐term open‐label extension study in Japan

2018 ◽  
Vol 31 (1) ◽  
pp. e13487 ◽  
Author(s):  
Shin Fukudo ◽  
Hiroto Miwa ◽  
Atsushi Nakajima ◽  
Yoshikazu Kinoshita ◽  
Masanori Kosako ◽  
...  
Keyword(s):  
Chronic Constipation ◽  
Phase Iii ◽  
Extension Study ◽  
Controlled Study ◽  
High Dose ◽  
Open Label ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Open Label Extension

scholarly journals Oxcarbazepine adjunctive therapy for partial seizures in Japanese pediatric patients: a randomized double-blind placebo-controlled study and open-label extension study

2019 ◽  
Vol 11 (1) ◽  
pp. 30-45
Author(s):  
Tateki Fujiwara ◽  
Rie Teshima ◽  
Ikuo Sugiyama ◽  
Ken Tsuchida ◽  
Yoko Ohtsuka
Keyword(s):  
Adjunctive Therapy ◽  
Pediatric Patients ◽  
Extension Study ◽  
Controlled Study ◽  
Partial Seizures ◽  
Open Label ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Open Label Extension

scholarly journals Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension

2020 ◽  
Vol 16 (9) ◽  
pp. 1455-1467 ◽  
Author(s):  
Neely Ivgy-May ◽  
Goeran Hajak ◽  
Gonnie van Osta ◽  
Sabine Braat ◽  
Qing Chang ◽  
...  
Keyword(s):  
Primary Insomnia ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Open Label Extension

Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension

2008 ◽  
Vol 16 (1) ◽  
pp. 31-43 ◽  
Author(s):  
Andreas Tzimos ◽  
Viktor Samokhvalov ◽  
Michelle Kramer ◽  
Lisa Ford ◽  
Cristiana Gassmann-Mayer ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Extended Release ◽  
Controlled Study ◽  
Open Label ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Open Label Extension ◽  
Paliperidone Extended Release
Sign in / Sign up

Export Citation Format

Share Document